Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by Donbgamecockon Mar 07, 2019 10:47am
82 Views
Post# 29455114

RE:Realistic expectations

RE:Realistic expectations
mpdsn777 wrote: I'm curious to get opinions on the realistic expectations for Aphria in 2019.

I personally feel that the likelihood of Aphria reaching the 20 CAD mark again is highly unlikely in the near term (if ever).

If appears that the whole sector is unravelling as a result of the self-dealing and the fact that earnings are lackluster at best.

Is it realistic that Aphria can achieve 15 CAD in the near future and 20 CAD in the long term?


First, are you talking fiscal or calendar year.  I would agree that it may be hard pressed to achieve a $20 SP by Aug 30 (fiscal year). I say that because Aphria one wont even acieve full rotation crop revenues by that date. But, i think it is very feasible to get a $20 SP in the fourth calendar quarter.  This is because we should see DD and the new extracter facillities come on line during the summer.

Also, none of my above statements includes CC Pharma or LATAM revenues which could easily be in the 50-75M per qtr.   
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse